交易 ResMed Inc - US - RMD
ResMed (RMD) is a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD) and other chronic diseases. SDB includes obstructive sleep apnoea (OSA), and other respiratory disorders that occur during sleep. The company’s products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. ResMed’s cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes and efficiencies for their customers. ResMed employs about 5,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. The ResMed share price is available at Capital.com.最新股票文章

韓股槓桿風險對照港股:熔斷常態化下的跨市場結構解析
2026 年的韓國股市,把「成熟新興市場」這個標籤推向極限。一個原本被視為波動較大但仍屬可控的市場,在短短一年之間,讓熔斷從罕見的技術事件轉變為近乎每月一次的常態風險管理工具。這場轉變並非單一衝擊所致,而是「高槓桿、高衍生品、高散戶、高主題集中」四重結構在同一時點交疊的必然結果。本報告從熔斷與邊車機制的頻繁啟動切入,逐層拆解這套結構如何把外部壓力與內部情緒迅速轉化為指數級的價格偏離,並持續對照港股制度,為投資者建立一個跨市場風險分析框架。
07:54, 20 8月 2026

三大技術指標 實戰捕捉美股見頂調整訊號
以標普500與納指為例,拆解50日及200日均線、RSI與MACD如何組成技術轉弱框架,協助讀者辨識短線回調與趨勢反轉。本文僅供一般資訊用途,不構成投資研究、投資建議或任何交易推薦。
07:26, 23 7月 2026

亞洲投資者如何了解SK hynix ADR的市場結構與相關風險
全面拆解SK hynix ADR(SKHY)交易機制:ADR換算比例、港股戶口執行路徑、韓圜匯率風險、與英偉達(NVDA)及半導體ETF的跨市場比較,以及AI供應鏈配置框架,適合香港及亞洲投資者參考。
07:10, 14 7月 2026

SpaceX 產業鏈與受惠股:從太空到 AI 再到防務
全面解析 SpaceX 產業鏈:從火箭推進、衛星載荷到地面段,逐一檢視美股、A股與港股受惠標的的功能對標與實際供貨差異,評估估值修復風險與跨市場波動傳導。
07:58, 22 6月 2026